Charts Week Month
Heat map Market Overview
Sentiment Sectors ETFs
Earnings News Earnings Movers The Drift Pivots
The Big Picture Breakouts Full Earnings News
Investor Services

Earnings are the driver of stock prices and the right earnings information can help longer-term investors significantly outperform the overall stock market.

The Whisper Report ® A look at upcoming earnings from both a top-down and bottom-up basis. Grades Stocks with A+ Earnings Whisper Grades Have Significantly Outperformed the Stock Market. Call Summaries Conference call summaries. AI Call Analysis AI Conference call analysis. Earnings Daily earnings results. Guidance Daily earnings guidance from companies. Reactions Earnings Screener Short Interest Report When the short trade becomes crowded.
Trader Service

Short-term earnings trading tools built around expectations, sentiment, quantitative studies, volatility, and post-earnings drift.

Trading Strategy The current strategy based on a broad market analysis and data. Earnings Whisper Plays Combining research, sentiment, quantitative studies, and technical analysis for short-term trades. Scores Identifying the likely Earnings Announcement Premium. Power Ratings Earnings with enough power for a short-term Post-Earnings Announcement Drift. Whisperings ^TM Whisperings are comments from analysts about upcoming earnings releases. AI Call Rankings Find which companies had the strongest or weakest conference calls. Option Trades Volatility Options Activity Unusual options activity around earnings. Setups Unusual options activity around earnings. Reversals Unusual options activity around earnings. Spikes Unusual options activity around earnings.
Dashboard

ICCC ImmuCell Corp.

NASDAQ

$10.05

ImmuCell Corp. (ICCC) Earnings News

Earnings press releases and Earnings Whispers previews for ImmuCell Corp. (ICCC), newest first.

Thursday August 13, 2026 4:05 PM ET

ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2026

Thursday August 6, 2026 4:05 PM ET

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2026

Thursday July 9, 2026 4:05 PM ET

ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results

Thursday May 14, 2026 4:05 PM ET

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026

Thursday May 7, 2026 4:05 PM ET

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026

Wednesday April 8, 2026 4:05 PM ET

ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results

Wednesday March 4, 2026 4:05 PM ET

ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025

Wednesday February 18, 2026 8:37 AM ET

ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025